Samir Patel Dds ,llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 332 Belleville Ave, Bloomfield, NJ 07003 Phone: 973-743-1755 Fax: 973-743-6199 |
Freda & Suriano Orthodontics Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 557 Broad St, Bloomfield, NJ 07003 Phone: 973-748-2248 Fax: 973-748-7004 |
Family Dental Associates Of Brookdale, L.l.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 988 Broad St, Bloomfield, NJ 07003 Phone: 973-338-6667 Fax: 973-338-1856 |
Children's Dental Specialists, Llc Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 382 W Passaic Ave, #2, Bloomfield, NJ 07003 Phone: 973-338-1383 |
Judith Samara Post D.m.d.,llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1460 Broad St, Bloomfield, NJ 07003 Phone: 973-338-9595 Fax: 973-338-9511 |
Royaldentalgroup Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6 Bloomfield Ave, Bloomfield, NJ 07003 Phone: 973-337-5879 Fax: 973-337-5102 |
News Archive
Bacteria have many methods of adapting to resist antibiotics, but a new class of spiral polypeptides developed at the University of Illinois targets one thing no bacterium can live without: an outer membrane.
For people suffering from rheumatoid arthritis, pain is the crucial factor in their personal perception of the condition. The doctors treating them, however, assess the severity of the disease based on the swelling of the joints. This discrepancy often leads to conflict between patients and their physicians, as a study by Daniel Aletaha and Paul Studenic from the University Department of Internal Medicine III at the MedUni Vienna has now revealed in more detail for the first time.
UNYQ, a pioneer in the field of design and 3D printing, announces the launch of its 3D-printed prosthetic leg socket, providing individuals with the perfect product to complement their prosthetic cover.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
› Verified 6 days ago